Phase II trial of docetaxal plus imatinib mesylate in the treatment of patients with metastatic breast cancer (Q43236873)

From Wikidata
Jump to navigation Jump to search
scientific article published in November 2009
edit
Language Label Description Also known as
English
Phase II trial of docetaxal plus imatinib mesylate in the treatment of patients with metastatic breast cancer
scientific article published in November 2009

    Statements

    Phase II trial of docetaxal plus imatinib mesylate in the treatment of patients with metastatic breast cancer (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit